Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
GILEAD SCIENCES, INC.
| Metric | GILEAD SCIENCES, INC. GILDHealthcare |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $29.44B |
| Net income (latest) | $8.51B |
| Operating margin | 34.0% |
| Net margin | 28.9% |
| Return on equity | 37.5% |
| Return on assets | 14.4% |
| Return on capital (ROCE) | 21.2% |
| Debt / equity | — |
| Revenue growth (YoY) | 2.4% |
| Altman Z″ (distress) | — |
| Accruals / assets | −2.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.